85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02648048 (ClinicalTrials.gov)	January 15, 2016	5/1/2016	A Study of Oral Vismodegibin Combination With Pirfenidone in Participants With Idiopathic Pulmonary ...	A Single Arm, Multicenter, Open-label, Phase 1b Study to Assess the Safety and Tolerability of Oral ...	Idiopathic Pulmonary Fibrosis	Drug: Pirfenidone;Drug: Vismodegib	Hoffmann-La Roche	NULL	Completed	40 Years	80 Years	All	21	Phase 1	United States;Germany
2	EUCTR2014-000963-42-DE (EUCTR)	01/10/2014	13/08/2014	A phase II study to assess vismodegib in the treatment of idiopathic pulmonary fibrosis	A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of ...	Idiopathic pulmonary fibrosis MedDRA version: 17.0;Level: PT;Classification code 10021240;Term: Idio ...	Trade Name: Erivedge INN or Proposed INN: vismodegib Other descriptive name: VISMODEGIB	F. Hoffmann-La Roche Ltd.	NULL	Not Recruiting			Female: yes Male: yes	129	Phase 2	United States;France;Mexico;Spain;Peru;Australia;Israel;Chile;Germany;New Zealand;Italy;Korea, Repub ...
3	NCT02168530 (ClinicalTrials.gov)	October 2014	18/6/2014	A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)		Idiopathic Pulmonary Fibrosis	Drug: placebo;Drug: vismodegib	Hoffmann-La Roche	NULL	Withdrawn	40 Years	N/A	Both	0	Phase 2	Australia;France;Germany;Israel;Korea, Republic of;Mexico;Peru;United States

First Previous1Next Last